These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 26206869

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Gene expression profile in the activation of subperitoneal fibroblasts reflects prognosis of patients with colon cancer.
    Yokota M, Kojima M, Higuchi Y, Nishizawa Y, Kobayashi A, Ito M, Saito N, Ochiai A.
    Int J Cancer; 2016 Mar 15; 138(6):1422-31. PubMed ID: 26370611
    [Abstract] [Full Text] [Related]

  • 4. Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer.
    Chida S, Okayama H, Noda M, Saito K, Nakajima T, Aoto K, Hayase S, Momma T, Ohki S, Kono K, Takenoshita S.
    Carcinogenesis; 2016 Sep 15; 37(9):878-887. PubMed ID: 27287872
    [Abstract] [Full Text] [Related]

  • 5. Proteomic Profiling of Human Prostate Cancer-associated Fibroblasts (CAF) Reveals LOXL2-dependent Regulation of the Tumor Microenvironment.
    Nguyen EV, Pereira BA, Lawrence MG, Ma X, Rebello RJ, Chan H, Niranjan B, Wu Y, Ellem S, Guan X, Wu J, Skhinas JN, Cox TR, Risbridger GP, Taylor RA, Lister NL, Daly RJ.
    Mol Cell Proteomics; 2019 Jul 15; 18(7):1410-1427. PubMed ID: 31061140
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer.
    Torres S, Bartolomé RA, Mendes M, Barderas R, Fernandez-Aceñero MJ, Peláez-García A, Peña C, Lopez-Lucendo M, Villar-Vázquez R, de Herreros AG, Bonilla F, Casal JI.
    Clin Cancer Res; 2013 Nov 01; 19(21):6006-19. PubMed ID: 24025712
    [Abstract] [Full Text] [Related]

  • 9. Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer.
    Wong JC, Chan SK, Schaeffer DF, Sagaert X, Lim HJ, Kennecke H, Owen DA, Suh KW, Kim YB, Tai IT.
    Clin Cancer Res; 2011 Jun 15; 17(12):4167-76. PubMed ID: 21531813
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y, Zhang M, Yu F, Lu S, Sun H, Tang H, Peng Z.
    J Exp Clin Cancer Res; 2015 Dec 01; 34():145. PubMed ID: 26626145
    [Abstract] [Full Text] [Related]

  • 12. Identification of stromal differentially expressed proteins in the colon carcinoma by quantitative proteomics.
    Mu Y, Chen Y, Zhang G, Zhan X, Li Y, Liu T, Li G, Li M, Xiao Z, Gong X, Chen Z.
    Electrophoresis; 2013 Jun 01; 34(11):1679-92. PubMed ID: 23737015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS, Kuppen PJ, Lee M, Lopatin M, Tezcan H, Putter H, Clark-Langone K, Liefers GJ, Shak S, van de Velde CJ.
    J Natl Cancer Inst; 2014 Nov 01; 106(11):. PubMed ID: 25261968
    [Abstract] [Full Text] [Related]

  • 15. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D, Merkel S, Croner R, Papadopoulos T, Brueckl W, Dimmler A.
    BMC Cancer; 2007 Aug 10; 7():156. PubMed ID: 17692120
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor-secreted LOXL2 activates fibroblasts through FAK signaling.
    Barker HE, Bird D, Lang G, Erler JT.
    Mol Cancer Res; 2013 Nov 10; 11(11):1425-36. PubMed ID: 24008674
    [Abstract] [Full Text] [Related]

  • 18. Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors.
    Fong SF, Dietzsch E, Fong KS, Hollosi P, Asuncion L, He Q, Parker MI, Csiszar K.
    Genes Chromosomes Cancer; 2007 Jul 10; 46(7):644-55. PubMed ID: 17394133
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.